2024 ICD-10-CM Diagnosis Code Q89.8

Approximate Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

• Abdominal fibromatosis
• Abnormal communication between pericardial sac and peritoneal cavity
• Abnormal fetal duplication
• Acardia
• Acardia
• Acephalobrachius
• Acephalogaster
• Aggressive fibromatosis
• Aggressive fibromatosis
• Aggressive infantile fibromatosis
• Aggressive systemic infantile myofibromatosis
• Amniotic adhesion
• Aplasia cutis congenita due to underlying malformation
• Borjeson-Forssman-Lehmann syndrome
• Cardiac anomaly and heterotaxy syndrome
• Celosomus
• Cephalodiprosopus
• CHARGE syndrome
• Coffin-Lowry syndrome
• Congenital absence of stomach
• Congenital anomaly of body cavity
• Congenital anomaly of body cavity
• Congenital anomaly of body wall
• Congenital anomaly of lower trunk
• Congenital anomaly of lymphatic structure of trunk
• Congenital anomaly of peritoneum
• Congenital anomaly of trunk
• Congenital anomaly of upper trunk
• Congenital deformity of soft tissue
• Congenital flat back deformity
• Congenital hemihypertrophy
• Congenital malformation of lymphatic system of cervicofacial region
• Congenital malformation of lymphatic vessel of skin
• Congenital malformation of vitreous humor
• Congenital malformation of vitreous humor
• Congenital malformation of vitreous humor
• Congenital malformation of vitreous humor
• Congenital pulmonary lymphatic dysplasia syndrome
• Congenital short trunk
• Derencephalus
• Developmental malformation of branchial arch
• Dicheirus
• Diprosopus
• Diprosopus tetrophthalmus
• Duplication of upper limb
• Dysplasia of lung
• Embryological remnant
• Hereditary disorder of lymphatic system
• Hereditary hyperekplexia
• Hereditary vitreoretinopathy
• Hereditary vitreoretinopathy
• Hereditary vitreoretinopathy
• Hereditary vitreoretinopathy
• Holoacardius acephalus
• Holoacardius amorphus
• Hyperekplexia epilepsy syndrome
• Hyperexplexia
• Hyperexplexia
• Hyperexplexia
• Infantile myofibromatosis
• Kabuki make-up syndrome
• Lymphatic malformation
• Marfanoid physique
• Mixed cystic lymphatic malformation
• Monocephalus
• Monocephalus tetrapus dibrachius
• Mullerian duct and limb anomalies syndrome
• Mullerian remnant
• Multicentric infantile myofibromatosis
• Multifocal lymphangioendotheliomatosis, thrombocytopenia syndrome
• Odontotrichomelic syndrome
• Omphaloangiopagus
• Parasitic twin of asymmetrical conjoined twins
• Peripheral demyelinating neuropathy, central dysmyelinating leukodystrophy, Waardenburg syndrome, Hirschsprung disease
• Persistent Müllerian duct syndrome
• PTEN hamartoma tumor syndrome
• Pygomelus
• Segmental outgrowth, lipomatosis, arteriovenous malformation, epidermal nevus syndrome
• Shprintzen Goldberg craniosynostosis syndrome
• Simonart's band
• Situs ambiguus
• Situs ambiguus
• Solitary infantile myofibromatosis
• Stickler syndrome
• Stickler syndrome type 1
• Stickler syndrome type 2
• Stickler syndrome type 3
• Stickler syndrome type 4
• Thoracodidymus
• Waardenburg Shah syndrome
• Waardenburg syndrome
• Waardenburg syndrome
• Waardenburg syndrome

Clinical Information

• Waardenburg Syndrome

  rare, autosomal dominant disease with variable penetrance and several known clinical types. characteristics may include depigmentation of the hair and skin, congenital deafness, heterochromia iridis, medial eyebrow hyperplasia, hypertrophy of the nasal root, and especially dystopia canthorum. the underlying cause may be defective development of the neural crest (neurocristopathy). waardenburg's syndrome may be closely related to piebaldism. klein-waardenburg syndrome refers to a disorder that also includes upper limb abnormalities.

• CHARGE Syndrome

  rare disease characterized by coloboma; choanal atresia; and abnormal semicircular canals. mutations in chd7 protein resulting in disturbed neural crest development are associated with charge syndrome.

• Stickler Syndrome

  a rare autosomal dominant syndrome caused by mutations in the col11a1, col11a2, and col2a1 genes which affect the production of type ii and xi collagen. it is characterized by a range of signs and symptoms including cleft palate, large tongue, small lower jaw, hearing loss, myopia, glaucoma, retinal detachment, skeletal, and joint abnormalities.

• Stickler Syndrome Type 1|STL1

  stickler syndrome inherited in an autosomal dominant pattern, caused by mutation(s) in the col2a1 gene, encoding collagen alpha-1(ii) chain.

• Stickler Syndrome Type 2|Stickler Syndrome Type II

  a rare autosomal dominant syndrome caused by mutations in the col11a1 gene. it is characterized by an abnormal ocular vitreous architecture (beaded vitreous phenotype). other signs and symptoms include retinal detachment, joint hypermobility, hearing loss, and midline clefting.

Q89.8 is grouped with Diagnostic Related Groups - MS-DRG Mapping

Diagnostic Related Groups (DRGs) are a classification system used to group together diagnosis codes for the purpose of reimbursement and healthcare management. DRGs are used to standardize the way hospitals and other providers are paid for inpatient services. In this system patients are grouped together based on their principal diagnosis in areas referred to as Major Diagnostic Categories (MDC). Once a patient is assigned a particular diagnostic category, providers receive a predetermined payment rate for the services rendered. This reimbursement rate is often fixed and is meant to cover the cost of care for that patient. Reimbursement is also affected by the relative weight of a diagnostic related group based on the severity of a patient's illness and the associated cost of care during hospitalization.

Diagnostic related groups encourage healthcare providers to focus on quality and efficiency in patient care while managing costs effectively. The diagnosis code is present in the following groups for version MS-DRG V41.0 applicable from 10/01/2023 through 09/30/2024.

The relative weight of a diagnostic related group determines the reimbursement rate based on the severity of a patient's illness and the associated cost of care during hospitalization.

Present on Admission (POA)

Q89.8 is exempt from POA reporting - The Present on Admission (POA) indicator is used for diagnosis codes included in claims involving inpatient admissions to general acute care hospitals. POA indicators must be reported to CMS on each claim to facilitate the grouping of diagnoses codes into the proper Diagnostic Related Groups (DRG). CMS publishes a listing of specific diagnosis codes that are exempt from the POA reporting requirement. Review other POA exempt codes here.

CMS POA Indicator Options and Definitions

Convert Q89.8 to ICD-9-CM

• ICD-9-CM Code: 759.89 - Specfied cong anomal NEC
  Approximate Flag - The approximate mapping means there is not an exact match between the ICD-10 and ICD-9 codes and the mapped code is not a precise representation of the original code.

Code History

• FY 2024 - No Change, effective from 10/1/2023 through 9/30/2024
• FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
• FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
• FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
• FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
• FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
• FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
• FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
• FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016. This was the first year ICD-10-CM was implemented into the HIPAA code set.